Category: Conferences & CLE’s

  • July 11-13, 2012 – Fundamentals of Patent Prosecution 2012: A Boot Camp for Claim Drafting & Amendment Writing (Practising Law Institute) – San Francisco, CA July 12, 2012 – Inducement to Infringe in Hatch-Waxman Litigation:  Lessons from Bayer Schering v. Lupin and AstraZeneca v. Apotex for Pharma Patents (Strafford) – 1:00 – 2:30 pm (EDT)…

  • D Young & Co. will be offering its next EPO biotechnology case law webinar on July 18, 2012.  The 45-minute webinar will be offered at three times: 4:00 am, 7:00 am, 12:00 pm (all times EDT).  Simon O'Brien and Robert Dempster will provide an essential update and live Q&A on EPO biotechnology case law. While…

  • C5 will be holding its 3rd Forum on EU Pharma Regulatory Law on September 25-26, 2012 in Brussels, Belgium.  The conference will provide presentations on the following topics: • Unraveling the Complexity to Ensure Effective Implementation of Pharamacovigilance (PV) Legislation• Adopting Effective Risk Management Strategies to Avoid Product Liability Claims• Safeguarding the Integrity of your…

  • The SMi will be holding its 4th annual conference on Biosimilars and Biobetters on September 24-25, 2012 in London, UK.  The conference will offer presentations on the following topics: • Clinical approach to biosimilar development;• Development of biosimilar monoclonal antibodies: opportunities and challenges;• Safety in biosimilar development;• Panel discussion: Biosimilars vs. biobetters, so which is…

  • July 11-13, 2012 – Fundamentals of Patent Prosecution 2012: A Boot Camp for Claim Drafting & Amendment Writing (Practising Law Institute) – San Francisco, CA July 12, 2012 – Inducement to Infringe in Hatch-Waxman Litigation:  Lessons from Bayer Schering v. Lupin and AstraZeneca v. Apotex for Pharma Patents (Strafford) – 1:00 – 2:30 pm (EDT)…

  • The Intellectual Property Owners Association (IPO) will be holding its 40th Annual Meeting on September 9-11, 2012 in San Antonio, TX.  Among the presentations being offered at the annual meeting are: • Patent Case Law Update• The America Invents Act – What Should Your Company or Client be Doing?• IPO's Corporate IP Benchmarking Survey: A…

  • By Kevin E. Noonan — Every year, Steve Burrill, President and CEO of Burrill & Co. takes the stage at the BIO International Convention and spends 90 minutes giving the audience his take on the state of the biotech nation.  And every year he has a theme:  upbeat optimism in 2008 followed by downright pessimism…

  • June 24-26, 2012 – IP Business Congress (Intellectual Asset Management (IAM) magazine) – Cascais, Portugal June 25-26, 2012 – Hatch-Waxman Boot Camp*** (American Conference Institute) – San Diego, CA July 11-13, 2012 – Fundamentals of Patent Prosecution 2012: A Boot Camp for Claim Drafting & Amendment Writing (Practising Law Institute) – San Francisco, CA July…

  • The Institute for International Research (IIR) will be holding its 13th Annual Business of Biosimilars & Generic Drugs conference from September 10-12, 2012 in Boston, MA.  The conference offer presentations on the following topics: September 10 — Summits• Biosimilar R&D Scenario Planning Session• Map the Strengths, Weaknesses, and Defenses of your IP Assets to Prepare…

  • Strafford will be offering a webinar/teleconference entitled "USPTO Post-Grant Proceedings:  Meeting the New Requirements for Post-Grant and Inter Partes Reviews and Supplemental Examination" on August 2, 2012 from 1:00 – 2:30 pm (EDT).  Greg H. Gardella, Scott A. McKeown, and Jessica J. Harrison of Oblon Spivak McClelland Maier & Neustadt will provide guidance on post-grant…